Bringing the fundamentals into focus…
Back to Aclaris Therapeutics, Inc.
How Aclaris Therapeutics, Inc. stacks up
ACRS · against 468 other Healthcare companies of similar size
Profitability
4/ 100
Near the bottom of its peers.
Ranked #456 of 469 · scores higher than 2% of peers
Bars: peers in each 10-point band of the profitability score41 peers with a profitability score of 0–9, including ACRS · Click a bar to see the companies
Why profitability scores 4?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 96% of peers. Operating margin: -1050.2% vs peer median 7.1%
- a lower return on assets: weaker than 91% of peers. Return on assets: -42.1% vs peer median 1.7%
- a lower return on invested capital: weaker than 90% of peers. Return on invested capital: -64.7% vs peer median 4.7%
Metric by metric
Position: dot = ACRS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ACRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 443 reported | -64.7% | 2.2% | 10% | 33% | |
| Operating marginHigher is better · 441 reported | -1050.2% | 4.8% | 4% | 33% | |
| Return on assetsHigher is better · 464 reported | -42.1% | 0.9% | 8% | 33% | |
| Return on equityHigher is better · 443 reported | -59.1% | 1.3% | 11% | Context only | |
| Gross marginHigher is better · 486 reported | 0.0% | 40.4% | 3% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ACRS| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 451 | 389M USD | 5 | 33 | |
| 451 | 327M USD | 5 | 11 | |
| 451 | 469M USD | 5 | 45 | |
| 451 | 549M USD | 5 | 30 | |
| 456 | 551M USD | 4 | 20 | |
| 456 | 387M USD | 4 | 49 | |
| 456 | 530M USD | 4 | 23 | |
| 456 | 453M USD | 4 | 6 | |
| 460 | 4.5B HKD (≈$579M) | 3 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score